Fc Receptor Proteins

Home
Products

products by category

Recombinant proteins
GMP Grade CytokinesNew Fc receptor proteins FcRn Proteins IgG Fc Proteins (Isotype Control) CGT development solutions New Key raw materials for CGT New Targets of CAR-T cell therapy Solid Tumor CAR Targets New CAR Targets for Hematological Malignancies New New Generation Tools for CAR DetectionStar Staining FDA DMF filed proteins Multi-pass TpsHot Immune checkpoint proteins ADC targets BsAb targets TME pathway targets Cytokine TargetsHot Enzymes Llama IgG Fc fusion protein Interleukin Protein Families Hot Biosimilar drug targets Biomarkers & CD antigens All recombinant proteins

Antibodies
Anti-idiotypic antibody Anti-FMC63 mAb Neutralizing antibodies IgG Isotype Control
Support on research about infectious diseases Hot
Core reagents for infectious disease researchNew SARS-CoV-2 related products Reagents for vaccine development SARS-CoV-2 mutant products SARS-CoV-2 related kits Reagents for diagnostic development
Kits/Beads
Cytokine detection ELISA kits New Pre-coupling magnetic beads Inhibitor Screening Kits ELISA Assay Kits for Quantitative analysis of therapeutic antibodies in serum

Featured products

Universal Tools
Star Ribbon Protein Marker New SA, SA Coated Plates, SA Magnetic Beads Hot MPCLIA Key Reagents New Anti-His Antibody New Anti-Human IgG Antibody New Anti-MMAE Antibody New Fc Receptor Proteins Hot IgG Fc ProteinsHot IgG Isotype ControlHot Serum AlbuminHot
Pre-labeled proteins
New Generation Tools for CAR DetectionStar Staining Biotinylated protein collection FITC & PE labeled proteins
Full-length multi-pass TpsHot
Multi-pass Tps FLAG Claudin Family Claudin 18.2 GPCRs CD20 proteins
Proteins for Neuroscience
Proteins for Neuroscience New Pre-formed Fibrils (PFFs) New Aneuro | Neural Factors New

Hot targets
CD19 BCMA CD3 proteins IL-2 and IL-2 receptor proteins Interleukin 4 Receptor proteinsNew IL-6 and IL-6 receptor proteins New VEGF proteins IGF family proteins New IFN family proteins New Chemokine family proteins New CD39/CD73 proteins B7 families TNFSF proteins PD1 proteins TIGIT Siglec-15 proteins Integrin CD24&siglec-10
Cytokines
Growth Factors for Cell Culture New Growth Factors for iPSC CulturingNew Growth Factors for Stem Cell TherapyNew Cytokines for Organoid CultureNew Promising Therapeutic Targets Hot

Brands
FLAG Star Staining ViruStop Aneuro ComboX ActiveMax GENPower ClinMax Star Ribbon
Services

Innovation Lab
SPR /BLI analytical serviceNew Quality Characterization Analytical Service New Enzyme-Linked Immunosorbent Assay (ELISA) Service New Meso Scale Discovery (MSD) ServiceNew Anti-Idiotypic Antibody Development ServiceNew Pseudovirus Neutralization Assay ServiceNew Custom GMP-grade Protein Services New MHC Class I Complex Custom ServiceNew Recombinant Antibody ServiceNew

Licensing Opportunities
PI3Kδ inhibitor New Capsid Assembly Inhibitors for HBVNew RET high selective inhibitor New A SSRI & Partial 5-HT1A Agonist New Reversible MAOB Inhibitor New sGC stimulator New Anti-B7H3 ADC New XO/URAT1 Dual target inhibitors for HUA New
Supports

How to Order Shipping & Payments Global Distributors Testimonials FAQs Download COA
Applications

The Process of How SARS-CoV-2 Infects the Host Quantitative Analysis of mAb in Serum Evaluation of CAR Expression Claudin18.2-VLP：designed for CAR detection SPR & BLI：Binding activity assay SEC-MALS: Aggregation state and purity
News

News Insights Promotions Exhibitions
Resources

Download Brochures Download E-resources Download COA
ACROBiosystems

About Us Join Us Contact Us Partner with us Quality management system

Introduction

The efficacy of a therapeutic antibody not only depends on the Fab fragment and its binding activity to the target antigen, but also depends on the Fc fragment and its interaction with key Fc receptors. The binding affinity of the Fc fragment towards FcRn (FCGRT&B2M) would predict the antibody’s half-life, while that between the Fc fragment and FcγRIIIa (CD16a) would influence the antibody’s ability to elicit ADCC (antibody dependent cell mediated cytotoxicity). Therefore, candidates must be tested against a panel of receptors during antibody engineering.

ACROBiosystems offers a comprehensive collection of recombinant Fc receptor proteins, including their common variants, to expedite your antibody drug development.

Hot targets

Advantages of Fc receptor protein products

Expressed by HEK293 Cells: post-translational modification and proper protein folding

Multiple species: Human, Mouse, Cynomolgus/Rhesus macaque, Rat, Porcine, Rabbit, Feline, Bovine, can be fully applied to different cross species experiments

High purity: SDS-PAGE verification purity>95%, SEC-MALS verification purity>90%

Low endotoxin: ＜1.0 EU/µg

High stability: strict quality control to ensure high batch-to-batch consistency

Biotinylated Fc Receptor proteins labeled with Avitag^TM offered: the labeling efficiency is high, and the labeling site is specific and clear, which is suitable for ELISA/SPR/BLI detection based on binding to streptavidin in the process of drug development and optimization process

Affinity verified by SPR & BLI: activity guaranteed, and protocols offered free of charge

Key features

High purity

To meet the high purity requirement of pharmaceutical applications, our production team perform both SDS-PAGE and SEC-MALS analyses to the Fc receptors for QC purposes. It’s noteworthy that it’s essential to use monomeric Fc receptor, which represents its natural state. The formation of oligomers during production may result in artificially enhanced binding interaction due to avidity effect. To avoid such situation, we have established strict internal control standards of monomer purity by SEC-MALS testing. Only those batches meeting all purity requirements are released.

Human CD32a (R167), His Tag (Cat. No. CDA-H5221) MALS images

Fig. 1 The purity of Human CD32a (R167), His Tag (Cat. No. CDA-H5221) is more than 95% verified by SDS-PAGE. The purity of Human CD32a (R167), His Tag (Cat. No. CDA-H5221) is more than 90% verified by SEC-MALS. And the molecular weight of this protein is around 25-35 kDa.

Bioactivity validated by SPR&BLI

The binding affinity between two molecules can be determined by many methods. However, the studies of Fc interaction are often done by SPR, because traditional ELISA is not appropriate for low affinity receptors such as CD16 and CD32. To assure our Fc receptors deliver expected performance, our QC team use Biacore platform to test our products against reference antibodies. Additionally, to meet more applications in the development of antibody drugs, our QC team also use ForteBio platform to test our products against reference antibodies. All SPR&BLI protocols are available for free.

Fig. 2 Human CD64, His Tag (SPR & BLI verified) (Cat. No. FCA-H52H1) captured on CM5 chip via anti-His antibody can bind Herc*ptin with an affinity constant of 4.92 nM as determined in a SPR assay (Biacore 8K) (QC tested).

Request SPR Protocol

Fig. 3 Immobilized Human FCGRT&B2M Heterodimer Protein, His Tag&Strep II Tag (SPR & BLI verified) (Cat. No. FCM-H5286) on CM5 Chip via Anti-His antibody, can bind Herc*ptin with an affinity constant of 0.261 μM as determined in a SPR assay (Biacore T200).

Request SPR Protocol

Fig. 4 Loaded Human CD64, His Tag (SPR & BLI verified) (Cat. No. FCA-H52H1) on HIS1K Biosensor, can bind Herc*ptin with an affinity constant of 6.98 nM as determined in BLI assay (ForteBio Octet Red96e).

Request BLI Protocol

Fig. 5 Loaded Human FCGRT&B2M Heterodimer Protein, His Tag (SPR & BLI verified) (Cat. No. FCN-H52W7) on SA Biosensor via Biotin his antibody, can bind Herc*ptin with an affinity constant of 0.14 μM as determined in BLI assay (ForteBio Octet Red96e).

Request BLI Protocol

High Batch-to-batch Consistency

We routinely apply rigorous quality control measures to ensure consistent performance of our product. As shown below, the batch variation among the tested samples is negligible.

Fig. 6 Immobilized Human Fc gamma RIIB / CD32b Protein (Cat. No. CDB-H5228) on CM5 Chip via anti-His antibody, can bind Ritux*mab with an affinity constant of 10 μM as determined in a SPR assay (Biacore T200).

Request SPR Protocol

We have compared the performance of different batches of CD32b (CDB-H5228) in the same assay, and the software analysis showed that the similarity score was very high, meaning high batch-to-batch consistency.

Fig. 7 Batch consistency of Human Fc gamma RIIB / CD32b (Cat. No. CDB-H5228). The consistency of different batches is more than 90%.

BIOTINYLATED OR OTHER SPECIES FC RECEPTORS AVAILABLE

The use of biotin labeling can make your assay development much easier. We offer a variety of ready-to-use biotinylated Fc receptors. These proteins are produced using our in-house developed labeling techniques, which confers high bioactivity and minimal batch-to-batch variation. In addition, we have developed a series of Fc receptors of other species, which are suitable for the screening of non-humanized antibodies or the species cross reaction.

Fig. 8 Biotinylated Human CD16a (V176), His Tag, Avi Tag (Cat. No.CDA-H82E9) captured on Biotin CAP- Series S Sensor Chip can bind Ritux*mab with an affinity constant of 0.261 μM as determined in a SPR assay (Biacore T200).

Request SPR Protocol

Fig. 9 Immobilized Cynomolgus / Rhesus macaque FcRn Protein (Cat. No. FCM-C5284) on CM5 Chip via anti-His antibody, can bind Herc*ptin with an affinity constant of 0.403 μM as determined in a SPR assay (Biacore T200).

Request SPR Protocol

Product list
(All Fc receptors are expressed from HEK293)